Oxidative Stress, Antioxidant Capacity, and Inflammatory Markers in Patients with Idiopathic Complete Heart Block by Shobhit Shah, Monika Bhandari, Pravesh Vishwakarma, Wahid Ali, Mohammad Kaleem Ahmad, Abhishek Singh, Ayush Shukla, Akhil Kumar Sharma, Gaurav Chaudhary, Akshyaya Pradhan, Sharad Chandra, Rishi Sethi, S. K. Dwivedi

“…Heart Views…”
Get full text

Efficacy of sacubitril/valsartan among patients with chronic heart failure with reduced ejection fraction by Madiha Butt, Ayesha Niazi, Zahra Rafique, Nadia Shams, Lubna Meraj, Asma Rauf

“… Objective: Chronic heart failure is one of the leading causes of hospitalization and recurrent admissions among the elderly population worldwide. …”
Get full text

“Path of the Heart” (The BPROAD Study) Addresses Optimal Systolic Blood Pressure for Patients With Diabetes by Ning Guang

Get full text

Recurrent Multivalvular Staphylococcus Lugdunensis Endocarditis Causing Complete Heart Block after TAVR by Preeti Singhal, Somsupha Kanjanauthai, Wilson Kwan

“…Six weeks post-TAVR, she presented with syncope, fever, and complete heart block. Transthoracic echocardiogram was not demonstrative of vegetation. …”
Get full text

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes by Ify R. Mordi, Aaron Tee, Colin N. Palmer, Rory J. McCrimmon, Alexander S.F. Doney, Chim C. Lang

Subjects: Get full text

The Heart-Placenta Axis in the First Month of Pregnancy: Induction and Prevention of Cardiovascular Birth Defects by Kersti K. Linask

“…Our studies demonstrate pathways and cell processes that are involved with protection of one-carbon metabolism during heart development.…”
Get full text

Sedentary behavior and physical activity on exercise capacity in adult patients with congenital heart disease by Masahiro Matsui, Keisei Kosaki, Naoto Kawamatsu, Yoshihiro Nozaki, Tomoko Machino-Otsuka, Yoshio Nakata, Seiji Maeda, Tomoko Ishizu

“…International Journal of Cardiology Congenital Heart Disease…”
Get full text

Cost-Effectiveness of the Prenatal Detection of Congenital Heart Diseases: A Systematic Literature Review by Darío Londoño Trujillo, Paula A. Castro García, Kristian K. Rojas López, Karen J. Moreno-Medina, María T. Dominguez Torres, Rodolfo J. Dennis Verano, Nestor F. Sandoval Reyes

“…**Background:** Congenital heart disease is the most common congenital condition worldwide, with a prevalence of 80 cases per 10 000 live births. …”
Get full text

Anesthesia Management for Pediatrics with Congenital Heart Diseases Who Undergo Cardiac Catheterization in China by Chun-Mei Xie, Yun-Tai Yao

“…The goal of this study was to summarize anesthesia management for pediatrics with congenital heart diseases who undergo cardiac catheterization procedure in China. …”
Get full text

His bundle pacing – a new word in technology of pacing and treatment of heart failure by Ya.V. Skybchyk, Ye.V. Zhytyns’kiy, О.М. Grytsay, V.О. Kuts, О.J. Zharinov

Subjects: Get full text

Hyponatremia and Congestive Heart Failure: A Marker of Increased Mortality and a Target for Therapy by Adam Romanovsky, Sean Bagshaw, Mitchell H. Rosner

“…Heart failure is one of the most common chronic medical conditions in the developed world. …”
Get full text

Association between exposure to particulate matter and heart rate variability in vulnerable and susceptible individuals by Yong Whi Jeong, Hayon Michelle Choi, Youhyun Park, Yongjin Lee, Ji Ye Jung, Dae Ryong Kang

“…Abstract Particulate matter (PM) exposure can reduce heart rate variability (HRV), a cardiovascular health marker. …”
Get full text

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction by Enrique Santas, Rafael de laEspriella, Patricia Palau, Gema Miñana, Martina Amiguet, Juan Sanchis, Josep Lupón, Antoni Bayes‐Genís, Francisco Javier Chorro, Julio Núñez Villota

Subjects: “…Heart failure…”
Get full text

Antiproteinase 3 Positive Eosinophilic Granulomatosis with Polyangiitis Presenting with Heart Failure and Intraventricular Thrombosis by Dan Zhu, Yiming Luo, Xiangyuan Liu, Lingyun Zu

“…We describe a case of anti-PR3 ANCA-positive EGPA complicated by congestive heart failure and intraventricular thrombosis. Interestingly, the thrombus was resolved rapidly with steroid and cyclophosphamide in the setting of interrupted anticoagulation. …”
Get full text

Fetal Heart Rate Patterns in Monochorionic Twins Following Acute Twin-Twin Transfusion by Shunji Suzuki, Nao Iwasaki, Shuichi Ono, Miwa Igarashi, Tomoaki Murata

“…These differences in changes of fetal heart rate in the donor twins following acute twin-twin transfusion may be resulted from the differences in amount of transfusion and elapsed time.…”
Get full text

Investigating the Effect of Testosterone Supplement on Heart and Muscle Damage in Rats Applied with Swimming Exercise by Ömer Kulaksız, Sefa Lök

Subjects: Get full text

Ivabradine and Milrinone—Bridge to Recovery in New HFrEF With Low-Output Heart Failure by Lekha Racharla, Lucas Gitzel, Max Joseph, Desire Guthier, Nael Hawwa

“…Evidence of structural heart improvement continued far beyond 1 year.…”
Get full text

Not “Much Room” in the Heart: A Rare Case of a Massive Intracardiac Candida Mass by Ali Haider Jafry, Sardar Hassan Ijaz, Murtaza Mazhar, Areeba Shahnawaz, Ali Yousif

Get full text

Chaotic gradient based optimization with fuzzy temporal optimized CNN for heart failure prediction by G. Kajeeth Kumar, S. Muthurajkumar

“…Abstract Heart failure is a leading cause of premature death, especially among individuals with a sedentary lifestyle. …”
Get full text

Functional Multipotency of Stem Cells: What Do We Need from Them in the Heart? by Pablo Díez Villanueva, Ricardo Sanz-Ruiz, Alberto Núñez García, María Eugenia Fernández Santos, Pedro L. Sánchez, Francisco Fernández-Avilés

“…After more than ten years of human research in the field of cardiac regenerative medicine, application of stem cells in different phases of ischemic heart disease has come to age. Randomized clinical trials have demonstrated that stem cell therapy can improve cardiac recovery after the acute phase of myocardial ischemia and in patients with chronic ischemic heart disease, and several efficacy phase III trials with clinical endpoints are on their way. …”
Get full text